AbbVie Inc (ABBV)

140.40
+2.36(+1.71%)
Pre Market
139.75
-0.65(-0.46%)
- Real-time Data
  • Volume:
    4,128,178
  • Day's Range:
    137.77 - 140.80
  • 52 wk Range:
    105.56 - 175.91
High dividend Yield

ABBV Overview

Prev. Close
138.04
Day's Range
137.77-140.8
Revenue
57.35B
Open
138.13
52 wk Range
105.56-175.91
EPS
7.1
Volume
4,128,178
Market Cap
248.13B
Dividend (Yield)
5.64
(4.02%)
Average Volume (3m)
6,161,164
P/E Ratio
19.53
Beta
0.675
1-Year Change
22.67%
Shares Outstanding
1,768,096,495
Next Earnings Date
04 Nov 2022
What is your sentiment on AbbVie?
or
Market is currently closed. Voting is open during market hours.

AbbVie Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

AbbVie Inc Analysis

AbbVie Inc Company Profile

AbbVie Inc Company Profile

Employees
50000

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products include Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyNeutralSellBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Buy
SummaryStrong BuyStrong BuyBuyStrong SellStrong Buy
  • Abbv going up again.
    0
    • What is happening to abbvie?
      0
      • ABBV : FDA requires updated warnings on JAK inhibitors citing increased risks of heart events10:56 am, Wed, Sep. 1, 2021
        0
    • Bullish guys
      0
      • Hi how will be EUR/USD next week
        8
        • Cloudy with a chance of rain
          0